54 related articles for article (PubMed ID: 24012547)
1. Interpretation of Farnesoid X Receptor Immunohistochemical Expression in Discriminating Hepatocellular Carcinoma from Its Non-Neoplastic Mimics as an Adjunct to Glypican 3.
Salama DEA; Shash LS; Shakweer MM; Abdel-Maqsoud RR; Ahmed Abosaif AI; Elgohary SA
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3221-3227. PubMed ID: 37774075
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: A clinicopathological and immunohistochemical study of 116 cases from a tertiary care hospital in Southern India.
Hui M; Uppin SG; Uppin MS; Madhav TV; Varma GSR; Paul TR; Bheerappa N
Indian J Cancer; 2023; 60(2):191-198. PubMed ID: 37530240
[TBL] [Abstract][Full Text] [Related]
3. Glypican-3-targeted precision diagnosis of hepatocellular carcinoma on clinical sections with a supramolecular 2D imaging probe.
Han HH; Qiu YJ; Shi YY; Wen W; He XP; Dong LW; Tan YX; Long YT; Tian H; Wang HY
Theranostics; 2018; 8(12):3268-3274. PubMed ID: 29930728
[TBL] [Abstract][Full Text] [Related]
4. Expression of glypican-3, SALL4, and CD34 in undifferentiated endometrial carcinomas.
Kihara A; Amano Y; Arai Y; Fujiwara H; Niki T
Pathology; 2024 Jun; 56(4):591-594. PubMed ID: 37872019
[No Abstract] [Full Text] [Related]
5. [Multidisciplinary experts consensus on diagnosis and treatment of precancerous lesions of hepatocellular carcinoma (2023 version)].
;
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1250-1261. PubMed ID: 38253068
[TBL] [Abstract][Full Text] [Related]
6. An update on anal neoplasia.
Fléjou JF
Histopathology; 2015 Jan; 66(1):147-60. PubMed ID: 25283345
[TBL] [Abstract][Full Text] [Related]
7. Shed antigen-induced blocking effect on CAR-T cells targeting Glypican-3 in Hepatocellular Carcinoma.
Sun L; Gao F; Gao Z; Ao L; Li N; Ma S; Jia M; Li N; Lu P; Sun B; Ho M; Jia S; Ding T; Gao W
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33833049
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer.
Mou H; Eskiocak O; Özler KA; Gorman M; Yue J; Jin Y; Wang Z; Gao Y; Janowitz T; Meyer HV; Yu T; Wilkinson JE; Kucukural A; Ozata DM; Beyaz S
J Pathol; 2023 Apr; 259(4):415-427. PubMed ID: 36641763
[TBL] [Abstract][Full Text] [Related]
9. Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma.
Zheng X; Liu X; Lei Y; Wang G; Liu M
Front Oncol; 2022; 12():824208. PubMed ID: 35251989
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous Development of Hepatocellular Carcinoma and B-Cell Lymphoma in Mosaic and Heterozygous Brca2 and Cdkn1a Interacting Protein Knockout Mice.
Lu H; Ye C; Feng X; Liu J; Bhaumik M; Xia B; Liu C; Shen Z
Am J Pathol; 2020 Jun; 190(6):1175-1187. PubMed ID: 32201259
[TBL] [Abstract][Full Text] [Related]
11. Normal Alpha-Fetoprotein Hepatocellular Carcinoma: Are They Really Normal?
Lee CW; Tsai HI; Lee WC; Huang SW; Lin CY; Hsieh YC; Kuo T; Chen CW; Yu MC
J Clin Med; 2019 Oct; 8(10):. PubMed ID: 31635078
[TBL] [Abstract][Full Text] [Related]
12. Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity.
Li W; Guo L; Rathi P; Marinova E; Gao X; Wu MF; Liu H; Dotti G; Gottschalk S; Metelitsa LS; Heczey A
Hum Gene Ther; 2017 May; 28(5):437-448. PubMed ID: 27530312
[TBL] [Abstract][Full Text] [Related]
13. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
14. Utility of glypican-3 and survivin in differentiating hepatocellular carcinoma from benign and preneoplastic hepatic lesions and metastatic carcinomas in liver fine-needle aspiration biopsies.
Nassar A; Cohen C; Siddiqui MT
Diagn Cytopathol; 2009 Sep; 37(9):629-35. PubMed ID: 19405109
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm.
Wang F; Jing X; Wang T; Li G; Li T; Zhang Q; Huang Y; Li J; Wang Y; Gao Y; Han T; Du Z
Am J Clin Pathol; 2012 Jun; 137(6):937-45. PubMed ID: 22586053
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of well-differentiated hepatocellular lesions: role of immunohistochemistry and other ancillary techniques.
Shafizadeh N; Kakar S
Adv Anat Pathol; 2011 Nov; 18(6):438-45. PubMed ID: 21993269
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry in the Diagnosis of Hepatocellular Carcinoma.
Choi WT; Kakar S
Gastroenterol Clin North Am; 2017 Jun; 46(2):311-325. PubMed ID: 28506367
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic role of glypican 3 and CD34 for differentiating hepatocellular carcinoma from nonmalignant hepatocellular lesions.
Enan ET; El-Hawary AK; El-Tantawy DA; Abu-Hashim MM; Helal NM
Ann Diagn Pathol; 2013 Dec; 17(6):490-3. PubMed ID: 24012547
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
